Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bramwell

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1981
Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in manJ Lankelma, P G Penders, A Leyva, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Cancer Treatment Reports|April 1, 1984
Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A Santoro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Human Pathology|September 1, 1996
The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerF P O'Malley, Z Saad, N Kerkvliet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancerM N Levine, M Gent, W M Hryniuk, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Clinical Biochemistry|June 1, 1996
Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal womenD S Bautista, Z Saad, A F Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Cancer & Clinical Oncology|November 1, 1981
Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in manJ Lankelma, P G Penders, A Leyva, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Cancer Treatment Reports|April 1, 1984
Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A Santoro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Human Pathology|September 1, 1996
The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerF P O'Malley, Z Saad, N Kerkvliet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancerM N Levine, M Gent, W M Hryniuk, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Clinical Biochemistry|June 1, 1996
Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal womenD S Bautista, Z Saad, A F Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Pageof 5